Literature DB >> 18815235

Role of the N-terminal amino acid of Bacillus anthracis lethal factor in lethal toxin cytotoxicity and its effect on the lethal toxin neutralization assay.

Anita Verma1, Leslie Wagner, Scott Stibitz, Nga Nguyen, Flor Guerengomba, Drusilla L Burns.   

Abstract

The cytotoxic activity of lethal factor (LF), a critical reagent used in the cell-based lethal toxin neutralization assay to assess anthrax vaccines, was shown to depend on the identity of its N-terminal amino acid, which plays a role in the targeting of LF to the proteasome for degradation. These results demonstrate that care must be taken to ensure that LF preparations used in standardized cell-based assays are not altered at their N-terminal ends.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815235      PMCID: PMC2583523          DOI: 10.1128/CVI.00081-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  17 in total

Review 1.  The N-end rule: functions, mysteries, uses.

Authors:  A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Authors:  N S Duesbery; C P Webb; S H Leppla; V M Gordon; K R Klimpel; T D Copeland; N G Ahn; M K Oskarsson; K Fukasawa; K D Paull; G F Vande Woude
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

3.  Expression and purification of the recombinant lethal factor of Bacillus anthracis.

Authors:  P Gupta; S Batra; A P Chopra; Y Singh; R Bhatnagar
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  In vivo half-life of a protein is a function of its amino-terminal residue.

Authors:  A Bachmair; D Finley; A Varshavsky
Journal:  Science       Date:  1986-10-10       Impact factor: 47.728

5.  Role of toxin functional domains in anthrax pathogenesis.

Authors:  F Brossier; M Weber-Levy; M Mock; J C Sirard
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  In vitro correlate of immunity in a rabbit model of inhalational anthrax.

Authors:  M L Pitt; S F Little; B E Ivins; P Fellows; J Barth; J Hewetson; P Gibbs; M Dertzbaugh; A M Friedlander
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

7.  Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.

Authors:  S F Little; B E Ivins; P F Fellows; M L M Pitt; S L W Norris; G P Andrews
Journal:  Vaccine       Date:  2004-01-02       Impact factor: 3.641

8.  Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.

Authors:  Conrad P Quinn; Peter M Dull; Vera Semenova; Han Li; Shane Crotty; Thomas H Taylor; Evelene Steward-Clark; Karen L Stamey; Daniel S Schmidt; Kelly Wallace Stinson; Alison E Freeman; Cheryl M Elie; Sandra K Martin; Carolyn Greene; Rachael D Aubert; John Glidewell; Bradley A Perkins; Rafi Ahmed; David S Stephens
Journal:  J Infect Dis       Date:  2004-08-30       Impact factor: 5.226

9.  Listeriolysin O secreted by Listeria monocytogenes into the host cell cytosol is degraded by the N-end rule pathway.

Authors:  Pamela Schnupf; Jianmin Zhou; Alexander Varshavsky; Daniel A Portnoy
Journal:  Infect Immun       Date:  2007-08-06       Impact factor: 3.441

10.  Validation of the anthrax lethal toxin neutralization assay.

Authors:  Donna Hering; William Thompson; John Hewetson; Stephen Little; Sarah Norris; Judith Pace-Templeton
Journal:  Biologicals       Date:  2004-03       Impact factor: 1.856

View more
  4 in total

1.  Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities.

Authors:  Tod J Merkel; Pin-Yu Perera; Vanessa K Kelly; Anita Verma; Zara N Llewellyn; Thomas A Waldmann; Joseph D Mosca; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.

Authors:  Leslie Wagner; Anita Verma; Bruce D Meade; Karine Reiter; David L Narum; Rebecca A Brady; Stephen F Little; Drusilla L Burns
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

3.  Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of Bacillus anthracis protective antigen.

Authors:  Anita Verma; Beth McNichol; Rocío I Domínguez-Castillo; Juan C Amador-Molina; Juan L Arciniega; Karine Reiter; Bruce D Meade; Miriam M Ngundi; Scott Stibitz; Drusilla L Burns
Journal:  Infect Immun       Date:  2012-10-31       Impact factor: 3.441

4.  Characterization of the native form of anthrax lethal factor for use in the toxin neutralization assay.

Authors:  Hang Lu; Jason Catania; Katalin Baranji; Jie Feng; Mili Gu; Janet Lathey; Diane Sweeny; Hannah Sanford; Kavita Sapru; Terry Patamawenu; June-Home Chen; Alan Ng; Zenbework Fesseha; Stefanie Kluepfel-Stahl; Jacob Minang; David Alleva
Journal:  Clin Vaccine Immunol       Date:  2013-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.